Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a
The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
Aberrancies of growth and proliferation-regulating mechanisms might be critically involved in the processes of neurodegeneration in Alzheimer's disease (AD). Expression of p21ras and further downstream signalling elements involved in regulation of proliferation and differentiation as, for example, MEK, ERK1/2, cyclins, cyclin-dependent kinases and their inhibitors such as those of the p16INK4a family, are elevated early during the course of neurodegeneration. Activation of p21ras can also directly be triggered by nitric oxide (NO), synthesized in the brain by various isoforms of nitric oxide synthase (NOS) that might be differentially involved into the pathomechanism of AD. To study the potential link of NO and critical regulators of cellular proliferation and differentiation in the process of neurofibrillary degeneration, we analyzed the expression pattern of NOS-isoforms, p21ras and p16INK4a compared to neurofibrillary degeneration in AD. Additionally to its expression in a subtype of cortical interneurons that contain the nNOS-isoform also in normal brain, nNOS was detected in pyramidal neurons containing neurofibrillary tangles or were even unaffected by neurofibrillary degeneration. Expression of nNOS in these neurons was highly co-localized with p21ras and p16INK4a. Because endogenous NO can activate p21ras in the same cell which in turn leads to cellular activation and stimulation of NOS expression [H.M. Lander, J.S. Ogiste, S.F.A. Pearce, R. Levi, A. Novogrodsky, Nitr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased levels of p53, a key mediator of cellular senescence and apoptosis, have been reported in different brain regions and in lymphocytes from AD patients [192,201,202,203], as well as in neurons of mouse models of AD [204].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [203]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Glutamate, nitric oxide and cell-cell signalling in the nervous system
Garthwaite, J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90022-m · Cited by 2,402
NITRIC OXIDE: A Physiologic Messenger Molecule
Bredt, D. S., & Snyder, S. H. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.001135 · Cited by 2,368
Nitric oxide, a novel neuronal messenger
Bredt, D. S., & Snyder, S. H. (1992) · Neuron · doi:10.1016/0896-6273(92)90104-l · Cited by 1,846
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Nitric Oxide Signaling in the Central Nervous System
Garthwaite, J., & Boulton, C. L. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003343 · Cited by 1,638
A Requirement for the Intercellular Messenger Nitric Oxide in Long-Term Potentiation
Schuman, E. M., & Madison, D. V. (1991) · Science · doi:10.1126/science.1720572 · Cited by 1,141
Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity
Zhang, J., Dawson, V. L., Dawson, T. M., & Snyder, S. H. (1994) · Science · doi:10.1126/science.8080500 · Cited by 1,118
Research works printed but not linked: 7
- Arendt, 1993, Neuronal dedifferentiation and degeneration in Alzheimer's disease, Biol. Chem. Hoppe-Seyler, 374, 911
- O.J. Bjerrum, C. Schafer-Nielsen, Analytical Electrophoresis, in: M.J. Dunn (Ed.), Verlag Chemie, Weinheim, 1986, p. 315.
- Gärtner, 1996, Neurofibrillary lesions in Alzheimer's disease are associated with 14-3-3 protein, Biol. Chem., 377, 180
- Gonzales-Zulueta, 1997, Nitric oxide activity-dependent neuronal survival, Soc. Neurosci. Abstr., 23, 630
- Heumann, 1996, Does neuronal modulation of p21 ras activity induce neurotrophic effects?, Soc. Neurosci. Abstr., 22, 1213
- Hindley, 1997, Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism, J. Neurosci., 15, 427
- Nagy, 1998, The cell division cycle and the pathophysiology of Alzheimer's disease, Neuroscience, 87, 731
Cited by
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Ras in Cancer and Developmental Diseases
Fernandez-Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 897
The physiology and pathophysiology of nitric oxide in the brain
Guix, F. X., Uribesalgo, I., Coma, M., & Muñoz, F. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.001 · Cited by 713
“…interacting with raf and triggers an MEK and extracellular signal-regulated kinases (ERK1/2) cascade pathway, playing a key role in proliferation, differentiation and apoptosis by the mod- ulation of cyclins, cyclin-dependent kinases and their inhibitors (Lander et al., 1996; Luth et al., 2000).”
BackgroundInfluentialAgeing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Alzheimer's disease: the two-hit hypothesis
Zhu, X., Raina, A. K., Perry, G., & Smith, M. A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00707-0 · Cited by 426
Metadata
- Authors
- Lüth, H. J., Holzer, M., Gertz, H.-J., & Arendt, T.
- Affiliations
- Leipzig University (DE)
- Corresponding author
- Lüth, H.J.
- ORCID
- Holzer, M.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2000-01
- Volume
- 852
- Issue
- 1
- Pages
- 45-55
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W1970205640
- Cited by
- 105
- References
- 112
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 1 · 2014: 4 · 2013: 5 · 2012: 3
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neuronal nitric oxide synthase, p21ras, p16INK4a, nitric oxide, neurofibrillary degeneration, pyramidal neurons, cortical interneurons, cell proliferation, neurodegeneration, colocalization
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Carrier Proteins, Female, Humans, Male, Reference Values, Proto-Oncogene Proteins p21(ras), Pyramidal Cells, Nitric Oxide Synthase, Cyclin-Dependent Kinase Inhibitor p16, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. https://app.cochat.ai/papers/10.1016/s0006-8993(99)02178-2
- The paper
- Lüth, H. J., Holzer, M., Gertz, H.-J., & Arendt, T. (2000). Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. Brain Research. https://doi.org/10.1016/s0006-8993(99)02178-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.